US FDA approves Novartis' kidney disease drug

Travere Therapeutics

07/08/2024 19:20

Aug 7 (Reuters) - The U.S. Food and Drug Administration
has approved the use of Novartis'  NOVN.S  drug to treat
patients with a type of kidney disease, the health regulator's
website showed on Wednesday.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi
Majumdar)
 ((Sriparna.Roy@thomsonreuters.com;))